Michael (@michael007here) header
Michael (@michael007here) profile picture

Michael

@michael007here

ignore the noise

 Austin, TX
Joined July 2015
  • Tweets828
  • Following642
  • Followers359
33Media
Photo by Michael (@michael007here)Photo by Michael (@michael007here)Photo by Michael (@michael007here)Photo by Michael (@michael007here)Photo by Michael (@michael007here)Photo by Michael (@michael007here)Photo by Michael (@michael007here)Photo by Michael (@michael007here)Photo by Michael (@michael007here)Photo by Michael (@michael007here)
Absolutely nothing has changed except the share price & that has nothing negative to do with $MDNAF , ignore the idiots and their juvenile post, it’s only noise, the story has not changed one bit.
4
2
1
17
12,664
Cytokines: $IBRX, $XLO, $CTMX, $MDNAF and the control challenge merlintrader.com/cytokines/ $MDNAF
Cytokines: $IBRX, $XLO, $CTMX, $MDNAF

Cytokines: $IBRX, $XLO, $CTMX, $MDNAF

Cytokines: $IBRX, $XLO, $CTMX and $MDNAF compared through IL-15, IL-12, interferon and IL-2, clinical evidence, funding and upcoming milestones.

merlintrader.com
1
1
230
Michael retweeted
dough (@semodough) profile picture
dough
@semodough9 Dec 2025
$MDNAF - Data update tomorrow
Joe (@Gantosj) profile pictureJoe
@Gantosj4 Dec 2025
$MDNAF $MDNA.to abstract at #ESMO-IO - important to note it's not the final poster as it's only a place-holder data cutoff 09/04 More updated data with most likely mid November will be presented next week 12/10 at the conference! The 2 slides are from AACR25 data cutoff 04/15/2025
Image from Joe (@Gantosj)
Image from Joe (@Gantosj)
Image from Joe (@Gantosj)
3
2
17
7,514
$MDNAF $MDNA.to $XBI You can wait for the 50–100 lymph-node biopsies. I won’t. PRISM-11 analysis of 1,000+ papers + every single MDNA11 responder now map to the exact same 7-axis repair pattern. Confidence this is what βγ-selective, LN-resident IL-2 actually does inside the node: >95 %. No other IL-2 molecule — past, present, or in clinic — can run this sequence. There can be only one.
Image from GypsyNoLonger | PRISM-11 (@GypsyNoLonger)
1
6
4
15
3,353
davidbakke.substack.com/p/md… $MDNA $MDNAF Why Patient Zero Was Never an Outlier How an “impossible” pancreatic cancer remission became the blueprint for the entire MDNA11 story. @Gantosj
2
13
525
davidbakke.substack.com/p/md… How Tumors Sabotage the Lymph Node (and How MDNA11 Rebuilds It) $MDNA $MDNAF Uptrending nicely before the big data MDNA11 readout December 10 at ESMO in the UK 💪 Can't wait 🙏 @Gantosj
4
13
867
16 Days to ESMO! $MDNAF
DonSmallCap 👑 (@Canuckfourlife) profile pictureDonSmallCap 👑@Canuckfourlife24 Nov 2025
davidbakke.substack.com/p/th… The Atlas Venture 2025 Update Quietly Reveals Why MDNA11 Is the Most Valuable Cytokine Asset in the World $MDNA $MDNAF 🚀 🫡
1
1
12
1,073
$MDNAF / $MDNA.to / $XBI 👑🚽ICI-naïve. VEGF-free. Essentially uCR w/ 100% tumor regression. The MDNA11 + Keytruda combo just did something special in MSS endometrial cancer. And Big Pharma should care. A lot! Read: 🔗 tinyurl.com/3xyxfy5m #oncology #biotech #immunotherapy #checkpointinhibitors #XBI #IL2 #EndometrialCancer
Image from GypsyNoLonger | PRISM-11 (@GypsyNoLonger)
1
4
1
15
736
$MDNAF / $MDNA.to $XBI 🚨🚨Article 10 is here! tinyurl.com/49hwfvbf #IL2 #biotech #cytokines
Image from GypsyNoLonger | PRISM-11 (@GypsyNoLonger)
1
3
11
948
$MDNAF / $MDNA.to Very much looking forward to the data next week at AACR! If you want to read what I've been working on, I've posted a few new articles over on my substack: shorturl.at/xOuSH
1
2
10
688
I don’t usually like my own post but this one seems really relevant again now . $MDNAF
2
1
7
601
Absolutely nothing has changed except the share price & that has nothing negative to do with $MDNAF , ignore the idiots and their juvenile post, it’s only noise, the story has not changed one bit.
4
2
1
17
12,664
Someone else is pretending to be Joe, the name is spelled differently. Joe @Gentocj I reported them.
2
198
FYI, someone pretending to be Joe G is sending out friend requests, they’re is a 1 at the beginning of his handle $MDNAF
1
1
2
2,086
ir.medicenna.com/news-releas… $MDNAF

Medicenna Commences Enrollment in the ABILITY-1 Study Combining MDNA11 with Pembrolizumab -...

The ABILITY-1 Study will evaluate MDNA11, a highly selective long-acting IL-2 Superkine, in combination with KEYTRUDA ® (pembrolizumab) for treatment of patients with advanced solid tumors MDNA11...

ir.medicenna.com
3
214
WARNING! I was contacted by someone impersonating @BioBoyScout, it appeared to be Robert's account, had his name and info, he asked for a contact # and I gave it, this morning the account has a different name,The Mining Bartender @ jttourzan, I was scammed, be careful. $ARWR
2
2
1
10
1,441
I have a dream, $MDNA
3
560
It's coming up soon! cytokine-immunotherapies.com… $MDNA
DonSmallCap 👑 (@Canuckfourlife) profile pictureDonSmallCap 👑@Canuckfourlife13 Jul 2022
$MDNA catching a bid before results in 2 weeks! 🔥 🚀
5
I'm looking for a steady rise until the Cytokine based drug development summit cytokine-immunotherapies.com…. MDNA-11 could be a game changer $MDNA
2
10
Load more